Delivery Order SPE2DB22D3501-SPE2DB24FVW38

Award Date 6/4/24
Potential Completion Date 6/26/24
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp. is a $17,968.39 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the medical product "WELIREG 40 MG TABLET 90S". The award has an ultimate completion date of February 10, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,368.14 firm fixed price delivery order is for the supply of 4565840111 WELIREG 40 MG TABLET 90S. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,968.39 and a completion date of January 6, 2025. It is a delivery order contract for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $17,368.14 to Amerisourcebergen Drug Corp for the supply of 4564762847 WELIREG 40 MG TABLET 90S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 Firm Fixed Price delivery order contract is for the supply of 4566639750 - WELIREG 40 MG TABLET 90S, with a period of performance through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $34,736.28 and is for the supply of the prescription medication WELIREG 40 MG TABLET 90S. The delivery order is a firm fixed price contract with an ultimate completion date of October 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including the drug WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and a completion date of February 26, 2025. It is a firm fixed-price contract and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVW38
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $34,736.28 Firm Fixed Price Delivery Order is for the supply of the drug WELIREG 40 MG TABLET 90S. The contract has an ultimate completion date of June 26, 2024.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The current contract award was made on a full and open competition basis without any set-aside designation.

Generated 9/3/24, 12:14 PM